This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospectively. Participants will be invited to wear another blinded sensor at 6 and 12 months.
Study Type
OBSERVATIONAL
Enrollment
40
Blinded CGM will be worn by all participants
Mount Sinai Hospital
New York, New York, United States
RECRUITINGTime in range
Time in range 70-180mg/dL
Time frame: 28 days
Percent time >180mg/dL
Percent time \>180mg/dL
Time frame: 28 days
Percent time >250mg/dL
Percent time \>250mg/dL
Time frame: 28 days
Percent time <70mg/dL
Percent time \<70mg/dL
Time frame: 28 days
Percent time <54mg/dL
Percent time \<54mg/dL
Time frame: 28 days
Transplant outcomes
Rate and time to of wound complications, vascular complications, biliary complications, acute kidney injury, transplant rejection, and readmissions
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.